An observational study evaluating the effect of dose optimization on trough levels in cancer patients treated with imatinib, sunitinib and pazopanib.

Trial Profile

An observational study evaluating the effect of dose optimization on trough levels in cancer patients treated with imatinib, sunitinib and pazopanib.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Nov 2016

At a glance

  • Drugs Imatinib (Primary) ; Pazopanib (Primary) ; Sunitinib (Primary)
  • Indications Cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Nov 2016 New trial record
    • 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top